Delivery Order SPE2DX15D1022-SPE2DX24FVDPG
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML, a specialty pharmaceutical product. The award, valued at $1,130.00, has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,649,492 units of the pharmaceutical product DURAMORPH 5 MG/10 ML AMPUL 10ML. The delivery order has a completion date of February 14, 2024 and a potential value of $3,385.23. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this award, which does not have a...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,781.70 order is for DURAMORPH 5 MG/10 ML AMPUL 10ML, a specialty pharmaceutical product, with a completion date of February 29, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00, to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product DURAMORPH 5 MG/10 ML AMPUL 10ML, with a ceiling value of $1,243.59 and a period of performance through March 22, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of up to $999,999,999.00 and a performance...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of DURAMORPH 10 MG/10 ML AMPUL 10ML pharmaceutical products. The contract has a completion date of February 9, 2024 and a potential value of $1,495.11. Amerisourcebergen Drug Corp provides a wide range of pharmaceutical and medical supplies to U.S. government agencies, including the Department...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order worth $2,042.55 for the supply of DURAMORPH 5 MG/10 ML AMPUL 10ML to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of October 7, 2024 and is a Firm Fixed Price type. AmerisourceBergen is the prime contractor, and there is no set-aside designation for this award. The contract is associated with a larger Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $1,309.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4563943727 - DURAMORPH 5 MG/10 ML AMPUL 10ML. The contract is a firm fixed price delivery order with a performance period through March 13, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31,...
- The Defense Logistics Agency awarded a delivery order valued at $1,581.99 to AmerisourceBergen Drug Corp for Duramorph 5 mg/10 mL ampuls on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $745.52 to Amerisourcebergen Drug Corporation for 4561817352 Duramorph 10 mg/10 ml ampuls. The delivery order calls for 10 ml ampuls of the narcotic analgesic Duramorph to be delivered by August 15, 2023 with performance taking place in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corporation will perform as the prime contractor for this requirement in support of the Defense Logistics Agency's medical supply...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide pharmaceutical products and medical supplies. The contract has a period of performance through April 2, 2024 and a ceiling value of $4,127.22. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used. This delivery order is part of a larger indefinite delivery...
- SPE2DX15D1022Indefinite Delivery Contract
- SPE2DX15D1022-SPE2DX24FVDPGDelivery Order
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide DURAMORPH 5 MG/10 ML AMPUL 10ML pharmaceuticals. The contract has a potential value of $3,563.40 and a completion date of February 14, 2024. This delivery order contract is under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 2/13/24 |